Clinical TrialsSearch results
Number of results: 2568
Completed
- A Study to Evaluate the Efficacy and Safety of Gantenerumab in Participants at Risk for or at the Earliest Stages of Alzheimer's Disease (AD)
- Preclinical AD
- Gesine Respondek, M.D.
- 2022-11-28
Completed
- A study to evaluate the immunogenicity and safety of smallpox vaccine as vaccination to monkeypox in healthy adults
- Monkeypox
- Ujiie Mugen
- 2022-06-30
Completed
- A Study to Evaluate the Long-Term Safety and Tolerability of Faricimab in Participants With Diabetic Macular Edema
- Diabetic Macular Edema
- Clinical trials information
- 2021-01-20
Completed
- A study to find a safe and effective dose of BI 1701963 alone and in combination with BI 3011441 in patients with advanced cancer and a certain mutation (Kirsten rat sarcoma viral oncogene homologue [KRAS])
- KRAS mutation positive solid tumours (Parts A and B), KRAS mutation positive NSCLC and CRC (Parts C
- WU HAOYU
- 2021-03-01
Completed
- A study to test different doses of BI 836880 combined with ezabenlimab in patients with advanced non-small cell lung cancer followed by other types of advanced solid tumours
- advanced solid tumours
- Yamagami Tomohiro
- 2020-11-18
Completed
- A Trial to Evaluate the Efficacy and Safety of RSVpreF in Infants Born to Women Vaccinated During Pregnancy.
- Respiratory Tract Infection
- Kawai Norisuke
- 2020-10-20
Completed
- A Trial to Learn Whether Regorafenib in Combination With Nivolumab Can Improve Tumor Responses and How Safe it is for Participants With Solid Tumors
- Solid Tumors
- Tanigawa Takahiko
- 2021-03-10
Completed
- Adding Radiotherapy to Enzalutamide in Nonmetastatic Castration-Resistant Prostate Cancer: A Phase II trial
- Prostatic Neoplasms, Castration-Resistant
- Yoshida Soichiro
- 2021-09-01
Completed
- Amcenestrant (SAR439859) plus palbociclib as first line therapy for patients with ER(+) HER2(-) advanced breast cancer
- Breast Cancer
- Tanaka Tomoyuki
- 2020-11-20
Completed
- An Exploratory Study of Dietary Management Apps in Adults with Type 2 Diabetes
- Type 2 diabetic
- Ishii Hideto
- 2022-12-07